Cargando…
Pulmonary DNA vaccination: Concepts, possibilities and perspectives
Mucosal immunity establishes the first line of defence against pathogens entering the body via mucosal surfaces. Besides eliciting both local and systemic immunity, mucosal vaccination strategies that are non-invasive in nature may increase patient compliance and reduce the need for vaccine applicat...
Autores principales: | Bivas-Benita, Maytal, Ottenhoff, Tom H.M., Junginger, Hans E., Borchard, Gerrit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7114572/ https://www.ncbi.nlm.nih.gov/pubmed/16054263 http://dx.doi.org/10.1016/j.jconrel.2005.05.028 |
Ejemplares similares
-
PLGA–PEI nanoparticles for gene delivery to pulmonary epithelium
por: Bivas-Benita, Maytal, et al.
Publicado: (2004) -
Pulmonary Delivery of Plasmid DNA for Disease Prevention and Therapy
por: Heuking, Simon, et al.
Publicado: (2011) -
Ag85A DNA Vaccine Delivery by Nanoparticles: Influence of the Formulation Characteristics on Immune Responses
por: Poecheim, Johanna, et al.
Publicado: (2016) -
Antibody glycosylation in inflammation, disease and vaccination
por: Alter, Galit, et al.
Publicado: (2018) -
How the Lack of Chitosan Characterization Precludes Implementation of the Safe-by-Design Concept
por: Marques, Cíntia, et al.
Publicado: (2020)